Expanding Measures of Benefit in Socioeconomic Studies
The purpose of socioeconomic studies of pharmaceutical interventions is to estimate analytically the value of those interventions. That valuation process should include all relevant costs and consequences, including side effects, risks, and benefits over all relevant time periods. Often, however, important consequences are not adequately considered by an analysis, which may result in misleading or the misinterpretation of results. Despite increasing interest  and methodological advances in the measurement of quality of life in drug studies, many otherwise methodologically sound socioeconomic studies do not include quality of life components, even when their inclusion could make a difference in the interpretation of value.
KeywordsImplantable Cardiac Defibrillator Psychometric Scale Valuation Process Relevant Time Period Socioeconomic Analysis
Unable to display preview. Download preview PDF.
- 2.Drummond MF, Stoddart GL, Torrance GW (1987) Methods for the economic evaluation of health care programmes. Oxford University Press, OxfordGoogle Scholar
- 5.Luce BR, Elixhauser A (1990) Standards for socioeconomic evaluation of health care products and services. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
- 6.Luce BR, Weschler JM, Underwood C (1989) The use of quality-of-life measures in the private sector. In: Mosteller F, Falotico-Taylor J (ed) Quality of life and technology assessment. National Academy Press, Washington DC, pp. 55–64Google Scholar
- 8.Warner KE, Luce BR (1982) Cost-benefit and cost-effectiveness analysis in health care: principles, practice and potential. Health Administration Press, University of MichiganGoogle Scholar